Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1088 participants.

Also called NCT07756398

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 1,088 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07756398
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07756398. Randomized; single masking; primary purpose screening. Start 2026-12-15 (anticipated); primary completion 2028-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)
Acronym
IMPROVE
Condition
Valvular Heart Disease Patients
Condition
Aortic Stenosis
Condition
Mitral Regurgitation
Condition
Left Ventricular Diastolic Dysfunction
Intervention (Device)
Kosmos Torso-One AI-guided Point-of-Care Ultrasound (EchoNous, Inc.)
Lead sponsor
University of Texas Southwestern Medical Center (class: other)

Record details

Record id
cardio:ct-nct07756398
Content hash
c5a388533b0db95f8967b2e17a72fbd609112f49f3caf04f92c260680b2fb625